Personalized vaccine shows promise against deadly skin cancer
NCT ID NCT03815058
Summary
This study tested whether adding a personalized cancer vaccine (autogene cevumeran) to standard immunotherapy (pembrolizumab) works better than immunotherapy alone for people with advanced melanoma that hasn't been treated before. The trial involved 131 patients with advanced skin cancer who received either the combination treatment or just the standard immunotherapy. Researchers measured how long patients lived without their cancer getting worse, how many responded to treatment, and monitored side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alfred Hospital
Melbourne, Victoria, 3181, Australia
-
Antwerp University Hospital
Edegem, 2650, Belgium
-
Atlanta Cancer Care
Alpharetta, Georgia, 30005, United States
-
Barts and The London
London, EC1M 6BQ, United Kingdom
-
Cancer Specialists
Jacksonville, Florida, 32256, United States
-
Case Western Research University
Cleveland, Ohio, 44106-5067, United States
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
Clinica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Elbe Kliniken Stade-Buxtehude GmbH
Buxtehude, 21614, Germany
-
Fachklinik Hornheide
Münster, 48157, Germany
-
Hospital Clinic de Barcelona
Barcelona, 08036, Spain
-
Hospital General Universitario Gregorio Marañon
Madrid, 28007, Spain
-
Hospital Universitario La Paz
Madrid, 280146, Spain
-
Hospital Universitario Virgen Macarena
Seville, 41009, Spain
-
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
Instituto Oncológico Dr. Rosell
Barcelona, 08028, Spain
-
Intermountain Surgical Oncology
Murray, Utah, 84107, United States
-
Liverpool Hospital
Liverpool, New South Wales, 2170, Australia
-
Massachusetts General Hospital.
Boston, Massachusetts, 02114, United States
-
Med. Fakultat Mannheim der Universitat Heidelberg
Mannheim, 68167, Germany
-
Moffitt McKinley Outpatient Center
Tampa, Florida, 33612, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Sarah Cannon Research Institute / Tennessee Oncology
Nashville, Tennessee, 37203, United States
-
Seattle Cancer Care Alliance
Seattle, Washington, 98109, United States
-
St. John of God - Subiaco Hospital
Subiaco, Western Australia, 6008, Australia
-
The Queen Elizabeth Hospital
Woodville South, South Australia, 5011, Australia
-
UCSF Comprehensive Cancer Ctr
San Francisco, California, 94115, United States
-
Uni Schleswig-Holstein
Lübeck, 23562, Germany
-
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik
Mainz, 55131, Germany
-
Universitatsklinikum Eppendorf
Hamburg, 20246, Germany
-
University of California San Diego Moores Cancer Center
La Jolla, California, 92037, United States
-
University of Colorado
Denver, Colorado, 80262, United States
-
University of Virginia
Charlottesville, Virginia, 22906, United States
-
Universitätshautk. Tübingen
Tübingen, 72076, Germany
-
Universitätsklinikum Heidelberg
Heidelberg, 69120, Germany
-
Universitätsklinikum Koeln
Cologne, 50937, Germany
-
Vall d?Hebron Institute of Oncology (VHIO), Barcelona
Barcelona, 08035, Spain
-
Washington University
St Louis, Missouri, 63110, United States
-
ZAS Sint Augustinus Wilrijk
Wilrijk, 2610, Belgium
Conditions
Explore the condition pages connected to this study.